On February 24, 2023, the DEA announced “Proposed Permanent Rules” for the prescribing of controlled medications on a telemedicine or telehealth basis.
Attached are:
A summary will follow later this week.
On February 24, 2023, the DEA announced “Proposed Permanent Rules” for the prescribing of controlled medications on a telemedicine or telehealth basis.
Attached are:
A summary will follow later this week.